Patents by Inventor Peter Marty

Peter Marty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYNTHESIS OF BACE INHIBITORS
    Publication number: 20160090360
    Abstract: The present invention provides a one step carbonylation of a compound of formula II in the presence of water to afford a compound of formula (I), useful in processes to manufacture BACE inhibitors.
    Type: Application
    Filed: April 23, 2014
    Publication date: March 31, 2016
    Inventors: Alec Fettes, Hans-Peter Marty, Michelangelo Scalone
  • Amines or amino alcohols as GLYT1 inhibitors
    Patent number: 8367838
    Abstract: The invention relates to the use of compounds of formula I wherein the substituents are described in the description and claims for the treatment of psychoses, dysfunction in memory and learning, schizophrenia, dementia, attention deficit disorders or Alzheimer's disease. The invention also relates to some compounds of formula I and pharmaceutical compositions containing them.
    Type: Grant
    Filed: May 25, 2012
    Date of Patent: February 5, 2013
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Sabine Kolczewski, Hans-Peter Marty, Robert Narquizian, Emmanuel Pinard, Henri Stalder
  • AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS
    Publication number: 20120232033
    Abstract: The invention relates to the use of compounds of formula I wherein the substituents are described in the description and claims for the treatment of psychoses, dysfunction in memory and learning, schizophrenia, dementia, attention deficit disorders or Alzheimer's disease. The invention also relates to some compounds of formula I and pharmaceutical compositions containing them.
    Type: Application
    Filed: May 25, 2012
    Publication date: September 13, 2012
    Inventors: Sabine Kolczewski, Hans-Peter Marty, Robert Narquizian, Emmanuel Pinnard, Henri Stalder
  • AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS
    Publication number: 20100210592
    Abstract: The invention relates to the use of compounds of formula I wherein the substituents are described in the description and claims for the treatment of psychoses, dysfunction in memory and learning, schizophrenia, dementia, attention deficit disorders or Alzheimer's disease. The invention also relates to some compounds of formula I and pharmaceutical compositions containing them.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 19, 2010
    Inventors: Sabine Kolczewski, Hans-Peter Marty, Robert Narquizian, Emmanuel Pinard, Henri Stalder
  • CB 1 receptor inverse agonists
    Patent number: 7579369
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, m and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.
    Type: Grant
    Filed: May 10, 2007
    Date of Patent: August 25, 2009
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Alexander Mayweg, Hans Peter Marty, Werner Mueller, Robert Narquizian, Werner Neidhart, Philippe Pflieger, Stephan Roever
  • Aminocycloalkanes as DPP-IV inhibitors
    Patent number: 7411093
    Abstract: The present invention relates to compounds of formula (I) wherein R1 is as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
    Type: Grant
    Filed: December 13, 2005
    Date of Patent: August 12, 2008
    Assignee: Hoffman-La Roche Inc.
    Inventors: Markus Boehringer, Daniel Hunziker, Bernd Kuhn, Bernd Michael Loeffler, Hans Peter Marty, Patrizio Mattei, Robert Narquizian
  • Risk stripping system and method
    Patent number: 7398242
    Abstract: A method is provided for managing risk associated with at least one financial transaction wherein each of the at least one financial transactions having at least a first risk factor and a second risk factor. The method includes a first step of receiving one of the at least one financial transactions. Next, in a second step, the first risk factor is transferred to a first risk book. The second risk factor is then transferred to a second risk book, in a third step. Next, in a fourth step, another of the at least one financial transactions is received. Finally, the second through fourth steps are repeated for each of the at least one financial transactions.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: July 8, 2008
    Assignee: UBS AG
    Inventors: Stephane Laederich, Peter Marty
  • CB 1 receptor inverse agonists
    Patent number: 7294644
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, m and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: November 13, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Alexander Mayweg, Hans Peter Marty, Werner Mueller, Robert Narquizian, Werner Neidhart, Philippe Pflieger, Stephan Roever
  • Pyrrolyl-thiazole derivatives
    Patent number: 7135488
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: November 14, 2006
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Wolgang Guba, Wolfgang Haap, Hans Peter Marty, Robert Narquizian
  • Novel CB 1 receptor inverse agonists
    Publication number: 20040167129
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: December 22, 2003
    Publication date: August 26, 2004
    Inventors: Alexander Mayweg, Hans Peter Marty, Werner Mueller, Robert Narquizian, Werner Neidhart, Philippe Pflieger, Stephan Roever
  • Novel pyrrolyl-thiazole derivatives
    Publication number: 20040147572
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: December 22, 2003
    Publication date: July 29, 2004
    Inventors: Wolfgang Guba, Wolfgang Haap, Hans Peter Marty, Robert Narquizian
  • Risk stripping system and method
    Publication number: 20020198823
    Abstract: A method is provided for managing risk associated with at least one financial transaction wherein each of the at least one financial transactions having at least a first risk factor and a second risk factor. The method includes a first step of receiving one of the at least one financial transactions. Next, in a second step, the first risk factor is transferred to a first risk book. The second risk factor is then transferred to a second risk book, in a third step. Next, in a fourth step, another of the at least one financial transactions is received. Finally, the second through fourth steps are repeated for each of the at least one financial transactions.
    Type: Application
    Filed: June 25, 2001
    Publication date: December 26, 2002
    Inventors: Stephane Laederich, Peter Marty